Sinclair IS Pharma sells epilepsy drug to Laboratoire SERB SAS
This article was originally published in Scrip
Executive Summary
Sinclair IS Pharma has sold the rights to its epilepsy drug, Mysoline (primidone), to its French distribution partner, Laboratoire SERB SAS, for a total cash consideration of £11.1 million